Analysis shows mDIXON-Quant imaging predicts glomerulosclerosis in chronic kidney disease, indicating potential for early diagnosis.
Motivation: Noninvasive prediction of renal fibrosis in patients with chronic kidney disease Goal(s): mDixon-Quant imaging was used to assess the proportion of glomerulosclerosis in patients with chronic kidney disease Approach: Two different measurements were used to quantify R2* and fat fraction (FF) generated by the mDIXON-Quant imaging technique, and the difference between low and high GS was analyzed. Results: Cortical R2* may be useful for early prediction of glomerulosclerosis in patients with CKD Impact: This study demonstrates that partial parameters obtained by two renal measurements of the mDixon-Quant sequence can noninvasively predict the proportion of glomerulosclerosis in patients with chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: